Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PFA 100 Evaluation and Reference Interval HOACNY

NCT06100510 is registered in ClinicalTrials.gov with Hematology Oncology Associates of Central New York as lead sponsor.

NCT NCT06100510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06100510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PFA 100 Evaluation and Reference Interval HOACNY
Lead sponsor
Hematology Oncology Associates of Central New York
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
February 19, 2024
Completion date
October 10, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effect of drug